Die chinesische Staatsführung intensiviert ihre Offensive in High-End-Fertigungsindustrien. Zu dem Ergebnis kommt eine neue Studie der AHK in China. Oliver Oehms, Vorstandsmitglied der AHK in Nordchina, hält es für deutsche Unternehmen für „entscheidend, dicht an den Entwicklungen zu bleiben“.
Von Leonardo Pape
Boehringer Ingelheim ist bereits seit 30 Jahren aktiv in China. Nun wird der deutsche Konzern in Shanghai eines seiner umsatzstärksten Präparate produzieren, das Diabetesmedikament Trajenta.
Von Redaktion Table
Boehringer Ingelheim has been active in China for 30 years. The German company will now produce one of its best-selling products, the diabetes drug Trajenta, in Shanghai.
Von Redaktion Table
China is tightening the requirements for subsidies for electric cars. This affects plug-in hybrids in particular.
Von Redaktion Table
The Chinese government is intensifying its offensive in high-end manufacturing industries. This is the conclusion of a new study by the German Chambers of Commerce Abroad (AHK) in China. Oliver Oehms, Board Member of the AHK in North China, believes it is "crucial for German companies to stay close to developments."
Von Leonardo Pape
In Xinjiang, China has tested the first airship wind turbine with an output of 1 MW. Although technically visionary, it remains an economic experiment for the time being.
Von Jörn Petring
The EU is urging swift action after China expanded its export restrictions on rare earths and high-tech products. Trade Commissioner Maroš Šefčovič is calling for talks with Beijing, while Lithuania and Denmark are calling for stronger economic security and a united European response.
Von Amelie Richter
In order to bring the Chinese-controlled tech producer Nexperia under control as pressure from the USA mounts, the Netherlands applied an emergency law from the 1950s. The EU should be in a better legal position to deal with similar cases in the future.
Von Marcel Grzanna und Fabian Peltsch
